vs
Side-by-side financial comparison of Abbott Laboratories (ABT) and NOVARTIS AG (NVS). Click either name above to swap in a different company.
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.5B | — | ||
| Q3 25 | $11.4B | — | ||
| Q2 25 | $11.1B | — | ||
| Q1 25 | $10.4B | — | ||
| Q4 24 | $11.0B | — | ||
| Q3 24 | $10.6B | — | ||
| Q2 24 | $10.4B | — | ||
| Q1 24 | $10.0B | — |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $9.2B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | 57.0% | — | ||
| Q3 25 | 55.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 55.6% | — | ||
| Q1 24 | 55.2% | — |
| Q4 25 | 19.6% | — | ||
| Q3 25 | 18.1% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 16.3% | — | ||
| Q4 24 | 17.4% | — | ||
| Q3 24 | 17.5% | — | ||
| Q2 24 | 16.1% | — | ||
| Q1 24 | 13.9% | — |
| Q4 25 | 15.5% | — | ||
| Q3 25 | 14.5% | — | ||
| Q2 25 | 16.0% | — | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | 84.1% | — | ||
| Q3 24 | 15.5% | — | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | 12.3% | — |
| Q4 25 | $1.01 | — | ||
| Q3 25 | $0.94 | — | ||
| Q2 25 | $1.01 | — | ||
| Q1 25 | $0.76 | — | ||
| Q4 24 | $5.26 | — | ||
| Q3 24 | $0.94 | — | ||
| Q2 24 | $0.74 | — | ||
| Q1 24 | $0.70 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
